Clinical Trial Update: Study of Paclitaxel, Carboplatin and Oral Metformin in the Treatment of Advanced Stage Ovarian Carcinoma [Phase 2]

View source ↗

Summary

A Phase 2 study is evaluating paclitaxel, carboplatin, and oral metformin for advanced epithelial ovarian cancer; the trial status is currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• PACLITAXEL (PACLITAXEL)
• metformin (metformin)

Snippet

Sponsor: Gynecologic Oncology Associates | Conditions: Epithelial Ovarian Carcinoma | Phase 2 | Status: UNKNOWN